CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · IEX Real-Time Price · USD
4.863
-0.087 (-1.76%)
At close: Jul 19, 2024, 4:00 PM
4.950
+0.087 (1.79%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

CollPlant Biotechnologies Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2015
Revenue
10.6210.960.315.646.142.32
Upgrade
Revenue Growth (YoY)
1495.20%3565.22%-98.09%154.86%164.75%-53.77%
Upgrade
Cost of Revenue
2.211.990.42.0131.88
Upgrade
Gross Profit
8.418.97-0.113.643.140.44
Upgrade
Selling, General & Admin
5.9566.745.944.673.66
Upgrade
Research & Development
10.7910.4810.267.634.074.41
Upgrade
Operating Expenses
16.7416.481713.578.738.07
Upgrade
Operating Income
-8.32-7.51-17.10.07-5.6-7.63
Upgrade
Interest Expense / Income
-0.49-0.49-0.17-0.1703.53
Upgrade
Other Expense / Income
-0.33---0.18-
Upgrade
Pretax Income
-7.5-7.02-16.930.24-5.77-11.16
Upgrade
Net Income
-7.5-7.02-16.930.24-5.77-11.16
Upgrade
Shares Outstanding (Basic)
1111111075
Upgrade
Shares Outstanding (Diluted)
1111111275
Upgrade
Shares Change
1.62%3.23%-7.80%73.76%38.12%13.73%
Upgrade
EPS (Basic)
-0.66-0.62-1.530.02-0.84-2.23
Upgrade
EPS (Diluted)
-0.68-0.62-1.530.02-0.84-2.23
Upgrade
Free Cash Flow
-3.39-3.65-15.010.95-4.97-7.16
Upgrade
Free Cash Flow Per Share
-0.30-0.32-1.360.10-0.72-1.44
Upgrade
Gross Margin
79.19%81.83%-33.78%87.18%51.08%18.94%
Upgrade
Operating Margin
-78.33%-68.55%-5718.06%0.42%-91.23%-329.21%
Upgrade
Profit Margin
-70.59%-64.05%-5660.54%1.52%-94.09%-481.62%
Upgrade
Free Cash Flow Margin
-31.90%-33.30%-5021.40%6.04%-80.98%-309.06%
Upgrade
EBITDA
-6.89-6.41-16.020.84-5.11-7.09
Upgrade
EBITDA Margin
-64.85%-58.49%-5358.19%5.36%-83.33%-305.95%
Upgrade
Depreciation & Amortization
1.11.11.080.770.660.54
Upgrade
EBIT
-7.99-7.51-17.10.07-5.77-7.63
Upgrade
EBIT Margin
-75.23%-68.55%-5718.06%0.42%-94.09%-329.21%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).